top of page

Technology

image for _our role and focus_ section  for a deep-tech SME specializing in on the transla

Overview

BioSense develops and translates advanced photonic and optoacoustic sensing technologies toward clinically relevant and deployable biomedical systems.

​

Our technology builds on strong scientific foundations while focusing on system integration, robustness, and relevance for real-world medical environments.

Microchip Inspection

Photonic and optoacoustic sensing

BioSense technologies are based on advanced biophotonic and optoacoustic sensing principles, enabling depth-resolved and label-free interrogation of biological tissue.

​

By combining optical excitation with acoustic detection, optoacoustic approaches provide access to functional and structural information that is difficult to obtain with purely optical or surface-weighted methods.

Multimodal signal acquisition and data analytics

BioSense develops integrated approaches for multimodal signal acquisition, electronics, and data analytics, enabling robust extraction of clinically meaningful features from complex biomedical signals. Emphasis is placed on reproducibility, noise rejection, and quantitative performance, supporting translation from laboratory demonstrations to relevant environments.

Data Analytics Screen
Soldering Circuit Board

System integration and miniaturization

A key focus of BioSense is the integration and miniaturization of advanced sensing technologies into compact, portable, and scalable systems. This includes optical and acoustic subsystem integration, dedicated electronics, thermal and mechanical stability considerations, and system-level optimization for usability and deployment beyond laboratory settings.

Translation toward medical devices

BioSense designs its technologies with translation in mind, supporting maturation toward non-invasive, regulatory-aware medical devices.

​Early consideration is given to clinical workflows, usability, safety, manufacturability, and exploitation pathways, reducing downstream risk and supporting progression toward clinical validation.

Regulatory awareness, medical device standards considerations, and alignment with MDR and CE-marking requirements are integrated early in the development process, supporting downstream clinical validation and deployment readiness.

Doctor Using Tablet

Technology disclosure and scope

Detailed technical specifications, performance metrics, and application-specific implementations are developed and disclosed in appropriate project, collaboration, or regulatory contexts. The information presented here reflects the underlying technological principles and translation approach, rather than product-specific claims.

bottom of page